Andon Bio Inc.
Biotech · Series A · Regulation D 506(b) · CO · Filed June 30, 2026
- Offering amount
- $2.0M
- Exemption
- Reg D 506(b)
- Issuer state
- CO
- Filing date
- June 30, 2026
- Signature date
- June 29, 2026
- CIK
- 0002142815
What is a Form D filing?
A Form D is the notice a private company files with the U.S. Securities and Exchange Commission when raising capital through an offering exempt under Regulation D (Rule 506(b), 506(c), or 504). It discloses the offering but is not a solicitation, an endorsement, or a statement of investment merit. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Public filing directories
Browse directories that group public SEC Form D records by the same filing tags shown on this page. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Summary
Auto-generatedThe issuer's name indicates a biotechnology focus, classifying it under biotech. This Colorado-based corporation filed a $2,000,000 offering under Rule 506(b) on June 30, 2026, anchoring a Series A stage.
Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Source
FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.